With such great presentations at the upcoming PharmSci360 conference, how do you decide what to attend?
We've put together a series of program guides to highlight Global Health topics at the conference to help you find the topics that interest you the most. See attached and copied below a list of topics related to Infectious Disease.
And don't forget to stop by the Global Health Community meeting form 4-5pm on Monday, Oct 21 at Spotlight Stage C.
---------
Monday
|
Time
|
Location
|
Poster / Presentation
|
Speaker
|
Title
|
|
9:00
|
155F
|
Presentation
|
Alex Langford, Pfizer
|
Accelerating Development of Vaccines for Low- and Middle-Income Countries
|
|
9:30
|
04-20
|
Poster
|
|
An Innovative Dual Action Antibiotic Adjuvant Strategy Using Ionic Liquid toward Synergistic Restoration of Activity in MDRO and Enhancing Antimicrobial Activity Against MRSA
|
|
9:30
|
09-52
|
Poster
|
|
Development and Characterization of pH-Sensitive, Ionizable Hybrid Nanocarriers for Enhanced Drug Delivery to Bacterial Biofilms
|
|
9:30
|
03-16
|
Poster
|
|
Optimizing Storage Conditions to Maintain Chemical Stability and Aerodynamic Performance of Tigecycline Inhalation Powder
|
|
11:30
|
07-40
|
Poster
|
|
Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
|
|
11:30
|
03-17
|
Poster
|
|
Enhancing Gonorrhea Vaccine Efficacy: Dosage Response Analysis of a Novel Microparticulate Formulation
|
|
12:30
|
09-52
|
Poster
|
|
An Exploratory Study of DHA-Incorporated Nanoformulations for Delivery of Antiretrovirals to Lymphatic HIV-Reservoirs
|
|
13:30
|
251 DE
|
Presentation
|
Brian Corrigan, Pfizer
|
Keynote: From Theory to Therapy: Charting the Course from the Lab to Global Health Outcomes in Translational Science
|
|
13:30
|
05-27
|
Poster
|
|
Design of Foamable Microemulsions for Vaginal Antifungal Drug Delivery
|
|
13:30
|
01-06
|
Poster
|
|
Formulation of a Poorly Soluble Antiviral Drug as Microparticle Powder for Nasal Breath Intake Against Respiratory Infections
|
|
13:30
|
01-05
|
Poster
|
|
Is a Minimally Invasive Amphotericin B Treatment Feasible? Nanocrystals-Loaded Microneedles for Cutaneous Leishmaniasis
|
|
13:30
|
05-29
|
Poster
|
|
Self-Nanoemulsifying Systems Containing Ionic Liquids of Rilpivirine for Improved Oral Bioavailability and Penetration in the HIV Sanctuary Sites
|
|
14:30
|
09-51
|
Poster
|
|
Aerosolizable Drug Loaded Superparamagnetic Iron Oxide Nanoparticle Theranostic for Pulmonary Tuberculosis
|
|
14:30
|
09-52
|
Poster
|
|
Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery
|
|
14:30
|
04-22
|
Poster
|
|
Discovery and Development of a New Therapeutic Product for the Treatment Long Covid
|
|
14:30
|
03-17
|
Poster
|
|
Targeted Antiretroviral Therapy Using Controlled Release Polymeric Nanoparticles for Brain Viral Load Reduction and Management of HIV Associated Neurocognitive Disorder (HAND)
|
|
15:30
|
10-59
|
Poster
|
|
Antimicrobial Polymer-siRNA Polyplexes as a Dual-Mode Platform for the Treatment of Wound Biofilm Infection and Inflammation Control
|
|
15:30
|
04-22
|
Poster
|
|
Anti-Viral and Anti-Inflammatory Effects of Novel PPARγ Agonist, INT131, in an EcoHIV Mouse Model: Relevance to the Treatment of HIV-Associated Neurocognitive Disorders
|
|
15:30
|
01-54
|
Poster
|
|
Development of an Aerosolizable Dry Powder of Mycobacteriophage D29 Using Thin-Film Freeze-Drying
|
|
15:30
|
06-35
|
Poster
|
|
Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
|
|
16:00
|
Spotlight Stage C
|
Meeting
|
|
Global Health Community Meeting
|
Tuesday
|
Time
|
Location
|
Poster / Presentation
|
Speaker
|
Title
|
|
7:00
|
Salt Lak AB
|
Event
|
|
Mentor Breakfast
|
|
9:30
|
05-26
|
Poster
|
|
On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
|
|
10:30
|
05-26
|
Poster
|
|
3D-Printed Short Nanofibers/Hydrogel-Based Vaginal Films as a Novel System for the Delivery of Anti-HIV Microbicide Drugs
|
|
10:30
|
3-16
|
Poster
|
|
Baru Nuts and Chia Seeds Extracts as Stabilizer in Nanostructured Formulation for Optimized Antifungal Drug Delivery of Fluconazole
|
|
10:30
|
251 F
|
Presentation
|
Reina Bendayan, University of Toronto
|
Novel Molecular Targets for the Treatment of HIV-Associated Neurocognitive Disorders
|
|
11:30
|
01-06
|
Poster
|
|
Nystatin-Loaded Microneedles via MeltPreP Vacuum Compression Molding for Prolonged Defense Against Candida albicans
|
|
12:30
|
05-30
|
Poster
|
|
Controlled Release Mannose and RVG-9R Functionalized PLGA Nanoparticles for Targeting the Brain Viral Reservoir for the Management of HIV Associated Neurocognitive Disorder
|
|
12:30
|
03-17
|
Poster
|
|
Development of Long-Acting Decoquinate Nanocrystal-Based Formulations as a Chemical Vaccine for Malaria
|
|
12:30
|
05*25
|
Poster
|
|
How are Medicines Administered to Pre-school Children? Current Status of a Global Survey on the Use of Dosing Vehicles
|
|
14:30
|
01-02
|
Poster
|
|
Development of an Extended Action Fostemsavir (FTR) Lipid Nanoparticle (LNP) Antiretroviral Therapy
|
|
14:30
|
03-16
|
Poster
|
|
Development of Microemulsion Formulations with D-Limonene and Terbinafine Hydrochloride for Treatment of Cutaneous Fungal Infections
|
|
15:30
|
05-25
|
Poster
|
|
Decorated Drug Nanocrystals as Highly-Loaded Trojan Horses for Nose-to-Brain Delivery in Cerebral Malaria
|
Wednesday
|
Time
|
Location
|
Poster / Presentation
|
Speaker
|
Title
|
|
9:00
|
251ABC
|
Presentation
|
Rohit Rao, Pfizer
|
Model-Informed Vaccine Development Opportunities
|
|
9:00
|
251DE
|
Presentation
|
Wendy Picking, University of Missouri-Columbia
|
A Dual Prophylactic/therapeutic Vaccine Against Pseudomonas Aeruginosa, Wendy Picking
|
|
9:30
|
251ABC
|
Presentation
|
Jeffrey Sachs, Merck
|
Pharmacometrics Symbiotically Infects Vaccinology: MIDD for Increasing PoS and Reducing Resource Use
|
|
9:30
|
251DE
|
Presentation
|
Li Li, Pfizer
|
Patient Focused Vaccine Drug Product Development: Formulation, Process and Manufacturing Approaches
|
|
9:30
|
155B
|
Presentation
|
Pavan Muttil, University of New Mexico
|
Inhaled Vaccines: Advancing Respiratory Infection Prevention and Overcoming Current Limitation
|
|
10:00
|
251ABC
|
Presentation
|
Will Lykins, AAHI
|
Case Studies of Rational Design and Translation for Next-Generation Vaccine Adjuvants
|
|
10:30
|
04-22
|
Poster
|
|
Antimicrobial Effects of S-nitrosothiols on Mycobacterium abscessus Biofilms
|
|
10:30
|
09-48
|
Poster
|
|
Comparison of Plant and Animal Sources of Squalene as Adjuvants for Use in Vaccine Applications
|
------------------------------
Erica Schlesinger Ph.D.
VP, Technical Development
Seran Biosciences, LLC
Bend OR
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------